DE602004013937D1 - Kombinationspräparate zur verhinderung von schlagand einen atii antagonisten enthalten - Google Patents

Kombinationspräparate zur verhinderung von schlagand einen atii antagonisten enthalten

Info

Publication number
DE602004013937D1
DE602004013937D1 DE602004013937T DE602004013937T DE602004013937D1 DE 602004013937 D1 DE602004013937 D1 DE 602004013937D1 DE 602004013937 T DE602004013937 T DE 602004013937T DE 602004013937 T DE602004013937 T DE 602004013937T DE 602004013937 D1 DE602004013937 D1 DE 602004013937D1
Authority
DE
Germany
Prior art keywords
protection
combination preparations
atii
antagonist
flags contain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602004013937T
Other languages
English (en)
Inventor
Lutz Hilbrich
James C Gilbert
David Humphreys
Axel Riedel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Boehringer Ingelheim Pharma GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32870338&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602004013937(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma GmbH and Co KG filed Critical Boehringer Ingelheim Pharma GmbH and Co KG
Publication of DE602004013937D1 publication Critical patent/DE602004013937D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE602004013937T 2003-02-13 2004-02-10 Kombinationspräparate zur verhinderung von schlagand einen atii antagonisten enthalten Expired - Fee Related DE602004013937D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10306179A DE10306179A1 (de) 2003-02-13 2003-02-13 Verwendung von Dipyridamol in Kombination mit Acetylsalicylsäure und einem Angiotensin II-Antagonisten zur Schlaganfall-Prophylaxe
EP03018212 2003-08-08
PCT/EP2004/001208 WO2004071385A2 (en) 2003-02-13 2004-02-10 Use of dipyridamole in combination with acetylsalicylic acid and an angiotensin ii antagonist for stroke prevention

Publications (1)

Publication Number Publication Date
DE602004013937D1 true DE602004013937D1 (de) 2008-07-03

Family

ID=32870338

Family Applications (2)

Application Number Title Priority Date Filing Date
DE10306179A Withdrawn DE10306179A1 (de) 2003-02-13 2003-02-13 Verwendung von Dipyridamol in Kombination mit Acetylsalicylsäure und einem Angiotensin II-Antagonisten zur Schlaganfall-Prophylaxe
DE602004013937T Expired - Fee Related DE602004013937D1 (de) 2003-02-13 2004-02-10 Kombinationspräparate zur verhinderung von schlagand einen atii antagonisten enthalten

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE10306179A Withdrawn DE10306179A1 (de) 2003-02-13 2003-02-13 Verwendung von Dipyridamol in Kombination mit Acetylsalicylsäure und einem Angiotensin II-Antagonisten zur Schlaganfall-Prophylaxe

Country Status (29)

Country Link
US (5) US20040214802A1 (de)
EP (2) EP1733729A1 (de)
JP (1) JP2006517557A (de)
KR (1) KR20050100676A (de)
CN (1) CN1750830A (de)
AR (1) AR043173A1 (de)
AT (1) ATE395921T1 (de)
AU (1) AU2004212305A1 (de)
BR (1) BRPI0407457A (de)
CA (1) CA2515941A1 (de)
DE (2) DE10306179A1 (de)
DK (1) DK1603573T3 (de)
EA (1) EA200501231A1 (de)
EC (1) ECSP055963A (de)
ES (1) ES2308147T3 (de)
HR (1) HRP20050713A2 (de)
MX (1) MXPA05008572A (de)
NO (1) NO20054216L (de)
NZ (1) NZ542302A (de)
PE (1) PE20050191A1 (de)
PL (1) PL378204A1 (de)
PT (1) PT1603573E (de)
RS (1) RS20050618A (de)
SI (1) SI1603573T1 (de)
TW (1) TW200501957A (de)
UA (1) UA83481C2 (de)
UY (1) UY28182A1 (de)
WO (1) WO2004071385A2 (de)
ZA (1) ZA200505956B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10335027A1 (de) * 2003-07-31 2005-02-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Angiotensin II Rezeptor Antagonisten
DE10306179A1 (de) * 2003-02-13 2004-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Dipyridamol in Kombination mit Acetylsalicylsäure und einem Angiotensin II-Antagonisten zur Schlaganfall-Prophylaxe
CA2437709A1 (en) * 2003-08-08 2005-02-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of dipyridamole, acetylsalicylic acid and an angiotensin ii antagonist for treatment and prevention of vascular events
JP2005060359A (ja) * 2003-08-13 2005-03-10 Boehringer Ingelheim Pharma Gmbh & Co Kg 血管系病態の治療及び予防のためのジピリダモール、アセチルサリチル酸及びアンギオテンシンｉｉ拮抗薬の使用
WO2009080301A1 (en) * 2007-12-21 2009-07-02 Boehringer Ingelheim International Gmbh Treatment and prevention of ischaemic cerebral lesions and cerebrovascular cognitive impairment using a treatment regimen consisting of dipyridamole and an angiotensin ii receptor blocker in patients with previous stroke
WO2009100534A1 (en) * 2008-02-14 2009-08-20 Kardiatech, Inc. Combination therapy to treat vascular disorders
US20100069326A1 (en) * 2008-02-14 2010-03-18 Wasimul Haque Combination Therapies to Treat Cardio- and Cerebro-Vascular Disorders
WO2010097501A2 (en) * 2009-02-26 2010-09-02 Orion Corporation A combination treatment
US8633158B1 (en) * 2012-10-02 2014-01-21 Tarix Pharmaceuticals Ltd. Angiotensin in treating brain conditions
TWI725008B (zh) * 2015-01-28 2021-04-21 瑞采生技有限公司 用於增強ＰＰＡＲγ表現及核轉位之化合物及其醫療用途

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3031458A (en) * 1958-02-05 1962-04-24 Ciba Pharm Prod Inc Isoindolines
US3031450A (en) 1959-04-30 1962-04-24 Thomae Gmbh Dr K Substituted pyrimido-[5, 4-d]-pyrimidines
US3317279A (en) * 1963-03-15 1967-05-02 Pennsalt Chemicals Corp Polymorph of calcium disilicide and its method of preparation
JPS5671074A (en) * 1979-11-12 1981-06-13 Takeda Chem Ind Ltd 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative
DE3000979A1 (de) 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
US4318477A (en) * 1980-09-22 1982-03-09 Kerpe Stase Z Pharmaceutical package
DE3124090A1 (de) 1981-06-19 1983-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale dipyridamolformen
CA1334092C (en) 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
DE3627423A1 (de) 1986-08-13 1988-02-18 Thomae Gmbh Dr K Arzneimittel enthaltend dipyridamol oder mopidamol und o-acetylsalicylsaeure bzw. deren physiologisch vertraegliche salze, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung der thrombusbildung
CA1338238C (en) 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
US4880804A (en) * 1988-01-07 1989-11-14 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking benzimidazoles
US5015651A (en) 1988-01-07 1991-05-14 E. I. Du Pont De Nemours And Company Treatment of hypertension with 1,2,4-angiotensin II antagonists
SI9210098B (sl) 1991-02-06 2000-06-30 Dr. Karl Thomae Benzimidazoli, zdravila, ki te spojine vsebujejo, in postopek za njihovo pripravo
EP1013273A1 (de) 1998-12-23 2000-06-28 Novartis AG Verwendung von AT-1 Rezeptorantagonisten oder AT-2 Rezeptormodulatoren zur Behandlung von Erkrankungen, die mit einer Erhöhung an AT-1 oder AT-2 Rezeptoren verbunden sind
SE9903028D0 (sv) * 1999-08-27 1999-08-27 Astra Ab New use
EP1093814A1 (de) * 1999-10-22 2001-04-25 Boehringer Ingelheim Pharma KG Verwendung von Dipyridamole oder Mopidamol zur Herstellung eines Medikaments für die Behandlung und Vorbeugung von fibrinabhängigen Mikrozirkulationstörungen
JP2002138054A (ja) * 2000-08-25 2002-05-14 Takeda Chem Ind Ltd フィブリノーゲン低下剤
JP2002293742A (ja) * 2001-01-29 2002-10-09 Takeda Chem Ind Ltd 鎮痛・抗炎症剤
JP2003212758A (ja) * 2001-03-16 2003-07-30 Takeda Chem Ind Ltd 徐放性製剤の製造法
DE10306179A1 (de) * 2003-02-13 2004-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Dipyridamol in Kombination mit Acetylsalicylsäure und einem Angiotensin II-Antagonisten zur Schlaganfall-Prophylaxe

Also Published As

Publication number Publication date
WO2004071385A3 (en) 2005-01-06
MXPA05008572A (es) 2005-11-04
US20080113949A1 (en) 2008-05-15
EP1733729A1 (de) 2006-12-20
ATE395921T1 (de) 2008-06-15
RS20050618A (en) 2007-09-21
HRP20050713A2 (en) 2006-09-30
US20080188497A1 (en) 2008-08-07
AR043173A1 (es) 2005-07-20
AU2004212305A1 (en) 2004-08-26
TW200501957A (en) 2005-01-16
US20040214802A1 (en) 2004-10-28
CA2515941A1 (en) 2004-08-26
PL378204A1 (pl) 2006-03-20
ECSP055963A (es) 2006-01-16
WO2004071385A2 (en) 2004-08-26
NO20054216D0 (no) 2005-09-12
EP1603573B8 (de) 2009-04-01
UA83481C2 (uk) 2008-07-25
PT1603573E (pt) 2008-06-26
ZA200505956B (en) 2006-03-29
CN1750830A (zh) 2006-03-22
NZ542302A (en) 2008-12-24
KR20050100676A (ko) 2005-10-19
DK1603573T3 (da) 2008-09-15
SI1603573T1 (sl) 2008-10-31
UY28182A1 (es) 2004-09-30
NO20054216L (no) 2005-09-12
JP2006517557A (ja) 2006-07-27
EP1603573B1 (de) 2008-05-21
ES2308147T3 (es) 2008-12-01
EA200501231A1 (ru) 2006-02-24
DE10306179A1 (de) 2004-08-26
US20060241089A1 (en) 2006-10-26
EP1603573A2 (de) 2005-12-14
US20070004687A1 (en) 2007-01-04
PE20050191A1 (es) 2005-04-12
BRPI0407457A (pt) 2006-01-31

Similar Documents

Publication Publication Date Title
DK1448523T3 (da) Heterocycliske forbindelser samt metoder til anvendelse deraf
DE602004014283D1 (de) System zur Einführung von mehreren Medizinprodukten
NO20042873L (no) Ladnings- eller partikkelavfoling
ATE512163T1 (de) Verabreichung von mitteln zur behandlung von entzündungen
DE60311307D1 (de) Shampoo-zusammensetzungen
EP1673343A4 (de) Verbindungen und zusammensetzungen als proteinkinaseinhibitoren
DK3494995T3 (da) Superfin formoterolformulering
EP1670771A4 (de) Verbindungen und zusammensetzungen als proteinkinaseinhibitoren
DE602004028754D1 (de) -substituierter diarylaminanaloga
HK1065259A1 (en) Water-in-oil emulsion cosmetic composition
ATE452638T1 (de) Ascomycin enthaltende ophthalmische zubereitungen
ATE491774T2 (de) Benzinzusammensetzung
DE502004006055D1 (de) 6-arylamino-5-cyano-4-pyrimidinone als pde9a-inhibitoren
FI20012483A0 (fi) MOSFETn avulla toteutettu polariteettisuoja
DE60316954D1 (de) Shampoozusammensetzungen
DK1704213T3 (da) Petroleumpræparat
DE602004013937D1 (de) Kombinationspräparate zur verhinderung von schlagand einen atii antagonisten enthalten
DE602004018858D1 (de) Emulsionszusammensetzung
EP1670780A4 (de) Verbindungen und zusammensetzungen als proteinkinaseinhibitoren
ITRM20050478A1 (it) Apparato per l'applicazione contemporanea della carbossiterapia e della mesoterapia.
ITMI20031313A1 (it) Associazioni di agenti vasoprotettori e formulazioni che li contengono.
DE60319319D1 (de) Augenheilkundegerät
FR2838646B1 (fr) Composition cosmetique pour tonifier le buste
DE602004016193D1 (de) Verfahren zur bekämpfung von unkräutern
NO20053428D0 (no) Fremgangsmate for dermal beskyttelse.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee